| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41380-020-00913-1 |
| P698 | PubMed publication ID | 33077852 |
| P50 | author | Cristina Crocamo | Q38590121 |
| Francesco Bartoli | Q38590131 | ||
| Tommaso Callovini | Q100737109 | ||
| Daniele Cavaleri | Q100737110 | ||
| Riccardo M Cioni | Q100737111 | ||
| Giuseppe Carrà | Q38590141 | ||
| Jonathan Savitz | Q43182872 | ||
| Blazej Misiak | Q58754282 | ||
| P2860 | cites work | Kynurenines in CNS disease: regulation by inflammatory cytokines | Q21129356 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial | Q24629398 | ||
| A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression | Q24630153 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Kynurenine pathway metabolites and suicidality | Q26773067 | ||
| Quinolinic acid, the inescapable neurotoxin | Q26991715 | ||
| Kynurenines in the mammalian brain: when physiology meets pathology | Q27003296 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia | Q28270694 | ||
| The kynurenine pathway: A missing piece in the puzzle of valproate action? | Q33355026 | ||
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 | ||
| Inflammation-associated depression: from serotonin to kynurenine | Q34147377 | ||
| Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder | Q34979782 | ||
| On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio. | Q35366914 | ||
| Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder | Q35647362 | ||
| Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder | Q36799359 | ||
| An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation | Q37254521 | ||
| Neurobiological trait abnormalities in bipolar disorder | Q37489488 | ||
| Cytokines in bipolar disorder: a systematic review and meta-analysis | Q38022942 | ||
| A Randomized Trial of the N-methyl-d-aspartate Receptor Glycine Site Antagonist Prodrug 4-chlorokynurenine in Treatment-Resistant Depression | Q90820360 | ||
| Tryptophan and Kynurenine Metabolites: Are They Related to Depression? | Q90960379 | ||
| The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response | Q91303004 | ||
| Targeting the immune system in the treatment of bipolar disorder | Q91523698 | ||
| Chemokine alterations in bipolar disorder: A systematic review and meta-analysis | Q91828937 | ||
| Ketamine and esketamine for suicidal ideation: Recent progress and practical issues | Q91923539 | ||
| Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis | Q92242703 | ||
| Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders | Q92338665 | ||
| A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder | Q92524912 | ||
| The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites | Q92604408 | ||
| Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression | Q92660354 | ||
| Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia | Q92802677 | ||
| The kynurenine pathway: a finger in every pie | Q93066099 | ||
| Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments | Q93177074 | ||
| Bipolar Disorder | Q96837853 | ||
| Advances toward precision medicine for bipolar disorder: mechanisms & molecules | Q97418693 | ||
| The HPA axis in bipolar disorder: Systematic review and meta-analysis | Q38627845 | ||
| Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. | Q38638172 | ||
| Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways | Q38665596 | ||
| L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences | Q38696755 | ||
| Tryptophan breakdown and cognition in bipolar disorder | Q38797809 | ||
| The kynurenine pathway and the brain: Challenges, controversies and promises | Q38832497 | ||
| The kynurenine pathway in schizophrenia and bipolar disorder. | Q38849243 | ||
| Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis. | Q38876575 | ||
| The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. | Q38938397 | ||
| Biological hypotheses and biomarkers of bipolar disorder | Q38995726 | ||
| Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis | Q39130393 | ||
| A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients | Q39273936 | ||
| Characterization of the kynurenine pathway in human neurons | Q40046237 | ||
| Serum kynurenic acid is reduced in affective psychosis. | Q41173215 | ||
| Bipolar disorder, schizophrenia, and metabolic syndrome | Q45090351 | ||
| Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? | Q46515190 | ||
| Bipolar mania and plasma amino acids: increased levels of glycine | Q46604090 | ||
| Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health | Q47659177 | ||
| The Emerging Neurobiology of Bipolar Disorder | Q47698386 | ||
| Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression | Q47722395 | ||
| Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression | Q47935886 | ||
| Kynurenine pathway and white matter microstructure in bipolar disorder | Q48041301 | ||
| A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality | Q48233112 | ||
| Tryptophan breakdown pathway in bipolar mania | Q48290210 | ||
| Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine | Q48481668 | ||
| Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients | Q50800821 | ||
| Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation | Q51888144 | ||
| Kynurenine pathway in depression: A systematic review and meta-analysis | Q52317183 | ||
| Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report. | Q54452819 | ||
| Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder. | Q55421233 | ||
| The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder | Q59795549 | ||
| Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies | Q60062706 | ||
| Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls | Q61807663 | ||
| Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry | Q72829466 | ||
| Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study | Q89507956 | ||
| Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder | Q90699785 | ||
| P921 | main subject | bipolar disorder | Q131755 |
| P577 | publication date | 2020-10-19 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites |
Search more.